AJMC October 26, 2023
The discussion, “Understanding Biomarkers and the Role They Play in Oncology,” came during the Community Oncology Alliance Payer Exchange Summit, held October 23-24 in Reston, Virginia.
The goal of precision medicine—to get “the right drug to the right patient at the right time”—is derailed when patients and their doctors hit a roadblock: insurers will not approve molecular genomic tests, or they will not do so without long prior authorization (PA) delays, which leave a window for cancer to advance.
This persists, despite trials that have revealed dozens of new targets across multiple cancers, especially in lung cancer, which still accounts for most cancer deaths. Evidence now shows that testing is not simply recommended, but that failure to do so can...
Today's Sponsors
Today's Sponsor